Literature DB >> 17543184

Pharmacological action and mechanisms of ginkgolide B.

Shi-hai Xia1, Dian-chun Fang.   

Abstract

OBJECTIVE: To review the recent research progress in pharmacological actions and mechanisms of ginkgolide B. Data sources Information included in this article was identified by searching of PUBMED (1987 - 2006) online resources using the key terms "ginkgolide B", "platelet activating factor", and "pharmacological". Study selection Mainly original milestone articles and critical reviews written by major pioneer investigators of the field were selected.
RESULTS: The key issues related to the pharmacological actions and mechanisms of ginkgolide B were summarized. The ginkgolide B possesses a number of beneficial effects such as anti-inflammatory, anti-allergic, antioxidant, and neuroprotective effects. Meantime, their mechaniams were discussed.
CONCLUSIONS: The Ginkgolide B is the most potent antagonist of platelet activating factor (PAF) and exhibits therapeutic action in a variety of diseases mainly by the PAF receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17543184

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  20 in total

1.  Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study.

Authors:  Maria Esposito; Marco Carotenuto
Journal:  Neurol Sci       Date:  2010-09-25       Impact factor: 3.307

Review 2.  Migraine with aura: conventional and non-conventional treatments.

Authors:  Giovanni D'Andrea; Davide Colavito; Maurizio Dalle Carbonare; Alberta Leon
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

3.  Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic stroke.

Authors:  Chun-Ling Chi; Dong-Fang Shen; Peng-Jun Wang; Hu-Lun Li; Li Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality.

Authors:  Chiara Di Lorenzo; Alessandro Ceschi; Hugo Kupferschmidt; Saskia Lüde; Elizabeth De Souza Nascimento; Ariana Dos Santos; Francesca Colombo; Gianfranco Frigerio; Karin Nørby; Jenny Plumb; Paul Finglas; Patrizia Restani
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

5.  Ginkgolide B Protects Against Ischemic Stroke Via Modulating Microglia Polarization in Mice.

Authors:  Zhao-Ma Shu; Xiao-Dong Shu; Hui-Qin Li; Yi Sun; Han Shan; Xi-Yang Sun; Ren-Hong Du; Ming Lu; Ming Xiao; Jian-Hua Ding; Gang Hu
Journal:  CNS Neurosci Ther       Date:  2016-06-16       Impact factor: 5.243

6.  Eotaxin increases monolayer permeability of human coronary artery endothelial cells.

Authors:  Md Saha Jamaluddin; Xinwen Wang; Hao Wang; Cubas Rafael; Qizhi Yao; Changyi Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

7.  Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Authors:  Jian-Ming Zhou; Sha-Sha Gu; Wang Hong Mei; Jun Zhou; Zhen Zhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2016-08-25       Impact factor: 3.667

8.  Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models.

Authors:  Hong Zhou; Jinsheng Gao; Li Zhou; Xin Li; Weidong Li; Xuejun Li; Yin Xia; Baoxue Yang
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-15

9.  The efficacy of ginkgolide B in the acute treatment of migraine aura: an open preliminary trial.

Authors:  Gianni Allais; Giovanni D'Andrea; Maurizio Maggio; Chiara Benedetto
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

10.  Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model.

Authors:  Xiaohan Yang; Tiezheng Zheng; Hao Hong; Nan Cai; Xiaofeng Zhou; Changkai Sun; Liying Wu; Shuhong Liu; Yongqi Zhao; Lingling Zhu; Ming Fan; Xuezhong Zhou; Fengxie Jin
Journal:  Front Med       Date:  2017-10-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.